Pharmacogenetics of the Late-Onset Efavirenz Neurotoxicity Syndrome (LENS)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetics of the Late-Onset Efavirenz Neurotoxicity Syndrome (LENS)
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-11-17
DOI
10.1093/cid/ciab961
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor–Containing Regimens
- (2020) Michael A Leonard et al. CLINICAL INFECTIOUS DISEASES
- Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre study
- (2018) F Guo et al. HIV MEDICINE
- A proposed management algorithm for late-onset efavirenz neurotoxicity
- (2018) H M Cross et al. SAMJ SOUTH AFRICAN MEDICAL JOURNAL
- Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites
- (2018) Eric H Decloedt et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Brief Report
- (2017) Ebrahim Variava et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship withCYP2B6c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous Meningitis
- (2016) Sam Nightingale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico , In Vitro , and In Vivo Investigation
- (2016) Paul Curley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa
- (2015) Phumla Z. Sinxadi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Combined Effect of CYP2B6 and NAT2 Genotype on Plasma Efavirenz Exposure During Rifampin-based Antituberculosis Therapy in the STRIDE Study
- (2015) A. F. Luetkemeyer et al. CLINICAL INFECTIOUS DISEASES
- Efavirenz and the CNS: what we already know and questions that need to be answered
- (2015) Nadezda Apostolova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Isoniazid Mediates theCYP2B6*6Genotype-Dependent Interaction between Efavirenz and Antituberculosis Drug Therapy through Mechanism-Based Inactivation of CYP2A6
- (2014) Michael H. Court et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PharmGKB summary
- (2014) Ellen M. McDonagh et al. Pharmacogenetics and Genomics
- Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients
- (2013) F. S. Sarfo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Sensitive and Selective Liquid Chromatography/Tandem Mass Spectrometry Method for Quantitative Analysis of Efavirenz in Human Plasma
- (2013) Praveen Srivastava et al. PLoS One
- Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
- (2013) Ulrich M. Zanger et al. Frontiers in Genetics
- Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants
- (2012) Emily R. Holzinger et al. Pharmacogenetics and Genomics
- Paradoxically elevated efavirenz concentrations in HIV/tuberculosis-coinfected patients with CYP2B6 516TT genotype on rifampin-containing antituberculous therapy
- (2010) Awewura Kwara et al. AIDS
- Efavirenz Primary and Secondary Metabolism In Vitro and In Vivo: Identification of Novel Metabolic Pathways and Cytochrome P450 2A6 as the Principal Catalyst of Efavirenz 7-Hydroxylation
- (2010) E. T. Ogburn et al. DRUG METABOLISM AND DISPOSITION
- Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes
- (2010) Margaret May et al. LANCET
- Presence of the CYP2B6 516G> T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patients
- (2010) Verena Gounden et al. AIDS Research and Therapy
- In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function
- (2009) Julia di Iulio et al. Pharmacogenetics and Genomics
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started